Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test | aidsmap
Cepheid | Cepheid | TB Drug-Resistance Testing | Xpert MTB-XDR
Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study - International Journal of Infectious Diseases
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis | NEJM
Early tuberculosis treatment monitoring by Xpert® MTB/RIF | European Respiratory Society
Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study | BMC Health Services Research | Full Text
Neutrophil-specific biomarkers as proxy for... | Documents | Open Research Africa
Estimated viable Mtb in sputum during the first 56 days of treatment... | Download Scientific Diagram
Juliana Furtado Gets the Lower-link VPP Treatment - Mountain Bike Press Release - Vital MTB
Funding Opportunities | Vanderbilt Tuberculosis Center
TropicalMed | Free Full-Text | Missing Cases of Bacteriologically Confirmed TB/DR-TB from the National Treatment Registers in West and North Sumatra Provinces, Indonesia
Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis – TB DIAH
Cepheid | Cepheid | TB Drug-Resistance Testing | Xpert MTB-XDR
![PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4b2748c6b14c22d792915b1e9fc3db2be946ae59/3-Figure2-1.png "PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar")
PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study | PLOS Medicine
Frontiers | Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
4.2 Adult and adolescent algorithms | MSF Medical Guidelines
Therapeutic host-directed strategies to improve outcome in tuberculosis | Mucosal Immunology
Frontiers | Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review
Integration of TB-LAM and Xpert MTB/RIF (Xpert) testing to improve TB case detection and shorten time to treatment initiation among People Living with HIV (PLHIV) in Harare City, Zimbabwe
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study | BMC Infectious Diseases | Full Text
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study | Scientific Reports
Xpert MTB/RIF Ultra Is Highly Sensitive for the Diagnosis of Tuberculosis Lymphadenitis in a High-HIV Setting | Journal of Clinical Microbiology
